vers la météo de la validation par utilisateur

Ingenuity377

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 33 - PMID ?

__NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hypertriglyceridemia .


Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante


Commentaires :
Analyse 0 
     +------------------------SUBJ:V_PASS-N------------------------+                                                                              
     |             +--------COMP:N-N(of)-------+                   |                                                                              
     |             |           +-MOD_ATT:N-ADJ-+                   |           +------COMP:N-N(of)-----+      +-----COMP:ADJ-N(to)----+           
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              +MOD_ATT:+MOD_PO+         +-MOD_ATT:N-N-+           
     |             |           |       |       |                   |           |              |        |      |         |             |           
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hypertriglyceridemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:N-N(of) (part,drug)
MOD_ATT:N-N (drug,combination)
MOD_POST:N-ADJ (drug,__NODE__)
COMP:ADJ-N(to) (__NODE__,hypertriglyceridemia)
MOD_ATT:N-N (hypertriglyceridemia,treat)
Analyse 1 
     +------------------------SUBJ:V_PASS-N------------------------+                                                                              
     |             +--------COMP:N-N(of)-------+                   |           +--------MOD_POST:N-ADJ--------+                                   
     |             |           +-MOD_ATT:N-ADJ-+                   |           +------COMP:N-N(of)-----+      +-----COMP:ADJ-N(to)----+           
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              +MOD_ATT:+      |         +-MOD_ATT:N-N-+           
     |             |           |       |       |                   |           |              |        |      |         |             |           
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hypertriglyceridemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:N-N(of) (part,drug)
MOD_POST:N-ADJ (part,__NODE__)
MOD_ATT:N-N (drug,combination)
COMP:ADJ-N(to) (__NODE__,hypertriglyceridemia)
MOD_ATT:N-N (hypertriglyceridemia,treat)
Analyse 2 
     +------------------------SUBJ:V_PASS-N------------------------+-------------------------COMP:V_PASS-N(to)------------------------+           
     |             +--------COMP:N-N(of)-------+                   |           +---------COMP:N-N(of)---------+                       |           
     |             |           +-MOD_ATT:N-ADJ-+                   |           |              +--MOD_ATT:N-N--+                       |           
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              |        +MOD_AT+         +-MOD_ATT:N-N-+           
     |             |           |       |       |                   |           |              |        |      |         |             |           
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hypertriglyceridemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:V_PASS-N(to) (approve,hypertriglyceridemia)
COMP:N-N(of) (part,__NODE__)
MOD_ATT:N-N (__NODE__,combination)
MOD_ATT:N-N (__NODE__,drug)
MOD_ATT:N-N (hypertriglyceridemia,treat)
Analyse 3 
     +------------------------SUBJ:V_PASS-N------------------------+                                                                              
     |             +--------COMP:N-N(of)-------+                   |           +---------COMP:N-N(of)---------+                                   
     |             |           +-MOD_ATT:N-ADJ-+                   |           |              +--MOD_ATT:N-N--+------COMP:N-N(to)-----+           
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              |        +MOD_AT+         +-MOD_ATT:N-N-+           
     |             |           |       |       |                   |           |              |        |      |         |             |           
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hypertriglyceridemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:N-N(of) (part,__NODE__)
MOD_ATT:N-N (__NODE__,combination)
MOD_ATT:N-N (__NODE__,drug)
COMP:N-N(to) (__NODE__,hypertriglyceridemia)
MOD_ATT:N-N (hypertriglyceridemia,treat)
Analyse 4 
     +------------------------SUBJ:V_PASS-N------------------------+           +---------------------COMP:N-N(to)---------------------+           
     |             +--------COMP:N-N(of)-------+                   |           +---------COMP:N-N(of)---------+                       |           
     |             |           +-MOD_ATT:N-ADJ-+                   |           |              +--MOD_ATT:N-N--+                       |           
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              |        +MOD_AT+         +-MOD_ATT:N-N-+           
     |             |           |       |       |                   |           |              |        |      |         |             |           
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hypertriglyceridemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
SUBJ:V_PASS-N (approve,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:N-N(of) (part,__NODE__)
COMP:N-N(to) (part,hypertriglyceridemia)
MOD_ATT:N-N (__NODE__,combination)
MOD_ATT:N-N (__NODE__,drug)
MOD_ATT:N-N (hypertriglyceridemia,treat)
Analyse 5 
                                                                   +------------------COMP:V_PASS-V(to)-----------------+                         
                   +--------COMP:N-N(of)-------+                   |           +---------COMP:N-N(of)---------+         |                         
                   |           +-MOD_ATT:N-ADJ-+                   |           |              +--MOD_ATT:N-N--+         |                         
     +----APPOS----+           |       +MOD_ATT+                   +COMP:V_PASS+              |        +MOD_AT+         +---OBJ:V-N---+           
     |             |           |       |       |                   |           |              |        |      |         |             |           
 __NODE__ , an inhibitor of __SP__ __NODE__ protein , has been approved as a part of the combination drug __NODE__ to treat hypertriglyceridemia .
APPOS (__NODE__,inhibiter)
COMP:N-N(of) (inhibiter,protein)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)
COMP:V_PASS-N(as) (approve,part)
COMP:V_PASS-V(to) (approve,treat)
COMP:N-N(of) (part,__NODE__)
MOD_ATT:N-N (__NODE__,combination)
MOD_ATT:N-N (__NODE__,drug)
OBJ:V-N (treat,hypertriglyceridemia)